Popular on Innoget
Publications
- View more
 | Seeking Recyclable Closure for Paper Beverage Bottles |
|
We are seeking technologies for a re-closable fiber-based closure for a paper beverage bottle that can be recycled in the paper stream. |
| | Seeking Recycling technologies for biodegradable films |
|
We are looking for solutions to convert bio-based packaging back to starting materials or other high-value added chemicals (no fuels). |
| | Seeking natural colors for foods and beverages |
|
PepsiCo is evaluating different natural color ingredients and technologies to replace Yellow #5, Yellow #6, Red #40, and Blue #1 for multiple food and beverage brands in order to address consumer demand. Specific challenges are in the Red #40 (food) and Blue #1 (food & beverage) replacers. |
 | Fast and non-sequential measurement method for the light response of chlorophyll a fluorescence |
|
New method for the measurement of the in vivo emission of chlorophyll a fluorescence by photosynthetic organisms, through the generation of light-response curves with independent observations, measured in a non-sequential and much faster way than the existing methods. The method combines the (i) projection in the sample of spatially separated light beams of different intensity or quality, using a digitally-controlled projector, with (ii) the measurement of the emitted fluorescence as a response to each light beam using an image fluorometer. |
 | RAR-related Orphan Receptor-γ Targeted Library |
|
The Retinoic Acid Receptor-related Orphan Receptor-γ (RORγ, RORc, NR1F3, RORG, RZR-GAMMA, RZRG, TOR or IMD42) plays an important role in metabolism, inimmunity and circadian rhythm. Abnormal functioning of RORγ is associated with inflammatory, immune and skin diseases including psoriasis. Antagonists and inverse agonists of this receptor may have therapeutic potential in the treatment of such diseases. https://bit.ly/461Jypm |
 | AgSept - Innovative Drug against viral diseases like pneumonia, Covid, or Rabies |
|
Unique formulation containing Silver nanoparticles (AgNP) with superior antiviral efficacy. Project 1: Anti Pneumonia Project 2: Anti Rabies Virus Advantages: Curative intravenous formulation to treat viral diseases in contrast to state of the art. At the moment only Vaccination, which means prophylactic treatment is available. (Some of the publications and presentations are courtesy and provided by my colleague Dr. Laura Wieler. ) |
Job opportunities
Introducing Innoget Jobs
Great innovation projects are built with
talented and creative people.
